Zepbound Weight Loss Insights

Order byBest matchMost fresh

Zepbound beats Wegovy for weight loss

More data back Zepbound over Wegovy for weight loss

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile, the group taking Zepbound (sold as Mounjaro for weight loss in some markets) also saw greater improvements in blood pressure, blood glucose, and cholesterol levels.

FOX 5 Atlanta · 1d

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

· 2d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

· 1d

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.

· 1d

This Drug Is Nearly 50 Percent More Effective Than Wegovy

· 1d

Eli Lilly’s Zepbound shows superior weight loss over Novo Nordisk's Wegovy in trial

Healio17h

Tirzepatide bests semaglutide for weight loss in adults with obesity

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the SURMOUNT-5 trial. As Healio previously reported,

New Atlas1d

Dual-target weight-loss drug is 47% more effective than its rival

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one clearly comes out on top.

The Associated Press on MSN12d

Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the ... Coach John Harbaugh provides insight.